Bioavailability of Duloxetine 60 mg vs Cymbalta in Healthy Fasting Subjects

Phase 1, randomised, open-label trial of duloxetine in major depressive disorder (MDD), generalized anxiety disorder (GAD), neuropathic pain and 1 more (2 arms), sponsored by Laboratorios Andromaco S.A. Primary endpoints: Area under the plasma concentration-time curve from 0 to 72 hours, Area under the plasma concentration-time curve from 0 to time t at 72 hours and 2 more. Started Jan 2021; status: completed.